<div>Apple co-founder Steve Jobs, who passed away today at the age of 56, had a rare form of pancreatic cancer called pancreatic neuroendocrine cancer, which produces islet cell or neuroendocrine tumors.
This form is usually less aggressive than pancreatic exocrine cancer and patients can live longer, with the average survival rate more than three years. Some people with the neuroendocrine form can live as long as 20 years.
Several forms of treatment are available. Jobs was diagnosed in 2003, had a liver transplant in 2009 and took an extended medical leave from Apple last January.
During his public appearances before he retired as Apple's CEO in August, it was evident Jobs had lost a significant amount of weight.
More...
This form is usually less aggressive than pancreatic exocrine cancer and patients can live longer, with the average survival rate more than three years. Some people with the neuroendocrine form can live as long as 20 years.
Several forms of treatment are available. Jobs was diagnosed in 2003, had a liver transplant in 2009 and took an extended medical leave from Apple last January.
During his public appearances before he retired as Apple's CEO in August, it was evident Jobs had lost a significant amount of weight.
More...